Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence.
about
Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patientsThe antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.Active Surveillance and Decolonization Without Isolation Is Effective in Preventing Methicillin-Resistant Staphylococcus aureus Transmission in the Psychiatry UnitsAnti-microbial Use in Animals: How to Assess the Trade-offs.Prevalence and Antimicrobial Resistance of Microbes Causing Bloodstream Infections in Unguja, ZanzibarCost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona.Extended-spectrum beta-lactamase--producing enterobacteriaceae in the intensive care unit: acquisition does not mean cross-transmission.Diminution of the gut resistome after a gut microbiota-targeted dietary intervention in obese children.Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000-2015).Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii.Burden of antimicrobial resistance in an era of decreasing susceptibility.Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department.Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections.Antimicrobial-resistant Escherichia coli in hospitalised companion animals and their hospital environment.The hidden cost of deep neck space infectionsy.Use of adjuvants in the treatment of Acinetobacter baumannii.Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections.Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China.Q59137228
P2860
Q26751621-1FCC33A7-7B6D-48EE-88F6-990632931AF8Q30379659-FE6D8401-F698-4338-99B0-441E5ECEAB67Q34802259-F9006055-0EBF-4B11-8B0C-38709D5A88E0Q35633181-AE890B63-866D-471C-B768-D4B438610490Q35877466-8E55DE19-E974-463A-823D-182EF43C7B3FQ35982731-D301C0DC-0EAB-4515-A0DB-4DF6E83A3D82Q35988906-1D78BFC9-B028-4EB7-B949-B376A9C674EAQ36765057-4F5E10A3-56E9-4ACB-AA40-FCDB5FFA2995Q38672110-42A0539F-3E05-469C-9FFF-79F8885DFD7AQ38697988-5525975F-DBAE-4CD8-8A87-9B8DAF2AEE03Q38805100-F129068E-0249-4938-8284-D2ED8ED79C57Q39350575-8B1ED170-0789-4F84-9A7D-B6008902C95EQ40311528-6DD12117-911E-4F49-A616-E522B37B5609Q40403794-47E97D6C-E0AB-4C58-9DFF-B8D08775B28AQ40622938-E172F1DD-5FA1-43C6-9369-3B26B267C7CFQ47766840-C0C359B3-83CE-42AC-B75D-5E2969461DCBQ53806892-41349C04-7F5F-4584-A00F-3CD8EE80D642Q54248806-796B2A7C-EB02-49CC-86D3-8E8CE38A1DB7Q54974996-BDACF27A-65D7-4C95-AD0B-FDC6252BB83EQ59137228-0BAD4213-86C3-43FA-8025-5A882E8FDFC5
P2860
Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Impact of antimicrobial multid ...... an evaluation of the evidence.
@en
type
label
Impact of antimicrobial multid ...... an evaluation of the evidence.
@en
prefLabel
Impact of antimicrobial multid ...... an evaluation of the evidence.
@en
P2860
P356
P1476
Impact of antimicrobial multid ...... an evaluation of the evidence
@en
P2093
Anastasios Kapaskelis
Giannoula S Tansarli
P2860
P304
P356
10.1586/ERI.13.4
P577
2013-03-01T00:00:00Z